SRI Researchers Validate Preclinical Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time

MENLO PARK, Calif., Nov. 29, 2011 /PRNewswire/ — In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time….

Leave a Reply

Your email address will not be published.

*